Navigation Links
Mount Kisco Medical Group and Northern Westchester Hospital Patients Participate in Development of New Cancer Medicine
Date:3/10/2015

Westchester County, NY (PRWEB) March 10, 2015

The Cancer Treatment and Wellness Center at Northern Westchester Hospital is pleased to announce that our patients who are participating in international clinical cancer research studies conducted in partnership with the Mount Kisco Medical Group (MKMG) are playing an important role in the further development of IBRANCE® (palbociclib) capsules, a treatment developed and manufactured by Pfizer Inc. The Cancer Treatment and Wellness Center (CTWC) at Northern Westchester Hospital (NWH) was one of the first sites in the world to make one of these studies available to patients.

Pfizer Inc. recently announced that the FDA approved IBRANCE® (palbociclib) capsules, the first-ever therapy targeting cyclin dependent kinases 4 and 6 (CDK4/6), for use in combination with letrozole to treat postmenopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer as initial endocrine-based therapy for their metastatic disease. To learn more about IBRANCE, and see the full prescribing information, please visit http://www.ibrance.com.

“The dedication and commitment of our patients and their willingness to participate in our palbociclib research trials continues to help evaluate this drug in other settings. This approval reinforces the importance of providing leading-edge care and access to investigational cancer drugs without having to travel outside of our community,” stated Dr. Jonathan Goldberg, Medical Oncologist at the Mount Kisco Medical Group and Medical Director of Cancer Clinical Trials at NWH. “MKMG and NWH are honored to be playing a role in the development of this and other innovative cancer treatments. The joint MKMG and NWH clinical trials program, in addition to serving our local patient population, has now become a destination for cancer patients from outside our community looking to gain access to these promising research studies."

For more information on other clinical trials underway, please contact the NWH Clinical Trials Program by visiting http://www.nwhc.net/clinicaltrials or by calling 914.666.1366.

About the Mount Kisco Medical Group
The Mount Kisco Medical Group (MKMG) is a multi-specialty medical group that provides the highest quality medical care in 40 different locations throughout Westchester, Putnam, Dutchess, and Ulster counties. Founded in 1946, MKMG has grown to over 450 physicians representing 40 different medical specialties with major campuses in Mount Kisco, Carmel, Katonah, Kingston, Fishkill, Jefferson Valley, Poughkeepsie and Rhinebeck. MKMG is affiliated with world class organizations: the Massachusetts General Hospital, Mount Sinai Medical Center and Memorial Sloan Kettering Cancer Center. MKMG has on-site laboratory and radiology services, as well as endoscopy suites and infusion suites, rendering comprehensive care in one convenient location. MKMG physicians are frequently recognized as Best Doctors in respected publications: 63 of the 293 physicians featured in Westchester Magazine’s Top Doctors are MKMG doctors. Additionally, Best Doctors of America® awarded 79 MKMG physicians with Top Doctor Honors. Visit http://www.mkmg.com for more information.

About Northern Westchester Hospital
Northern Westchester Hospital(NWH), a member of the North Shore-LIJ Health System, provides quality, patient centered care that is close to home through a unique combination of medical expertise, leading edge technology, and a commitment to humanity. Over 700 highly skilled physicians, state-of-the-art technology and professional staff of caregivers are all in place to ensure that you and your family receive treatment in a caring, respectful and nurturing environment.

NWH has established extensive internal quality measurements that surpass the standards defined by the Centers for Medicare & Medicaid Services (CMS) and the Hospital Quality Alliance (HQA) National Hospital Quality Measures. Our high quality standards help to ensure that the treatment you receive at NWH is among the best in the nation. For more information, please visit http://www.nwhc.net and connect with us on Facebook.

  • ### -
Contact:
Mark Vincent
Northern Westchester Hospital
914.666.1200

Read the full story at http://www.prweb.com/releases/2015/03/prweb12569466.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. National Association of Professional Women Announces Elizabeth C. Abel, M.S.W., Project Director, CAPP of City of Mount Vernon-Youth Bureau, as VIP Woman of the Year
2. Pradaxa Lawsuits Continue to Mount, With Filing of New Pradaxa Wrongful Death Claim in Pennsylvania by Wright & Schulte LLC
3. Mount Sinai Dermatology Department in NY Opens New Practice in Chinatown
4. Mount Sinai Makes Innovation a Team Effort At Its Second Annual Sinainnovations Conference, November 18-19, 2013 In NYC
5. Mount Sinai's Novel Gene Therapy Works to Reverse Heart Failure
6. Lipitor Lawsuits Continue to Mount, as Bernstein Liebhard LLP Notes Filing of New Claim Alleging an Association Between Lipitor and Diabetes
7. Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Mounting Claims Involving Risperdal Gynecomastia Allegations in Pennsylvania Litigation
8. Mount Sinais Arvin Dar, Ph.D., receives NIH New Innovator Award for drug development
9. Mirena Lawsuits Continue to Mount, As Bernstein Liebhard LLP Notes Filing of New Claim on Behalf of Alleged Victim of Mirena Complications
10. A Best Manuscript Award Goes to the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai
11. A Best Manuscript Award goes to Icahn School of Medicine at Mount Sinai
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2020)... ... February 19, 2020 , ... ... and application deadline for its new Lifestyle Medicine Residency Curriculum (LMRC). The curriculum ... implementation into medical residency programs. Driven by resident involvement, the curriculum has ...
(Date:2/19/2020)... ... February 19, 2020 , ... MedTech ... Encouraged to Apply to Participate in 2020 Cohort , The Massachusetts Medical Device ... program is now accepting applications from startup founders and CEOs to participate in ...
(Date:2/19/2020)... NEEDHAM, Mass. (PRWEB) , ... February 19, 2020 ... ... improve the quality and consistency of healthcare delivery, announced that it will participate ... 13, 2020, in Orlando, Florida. BPM+ Health will engage healthcare professionals and other ...
(Date:2/19/2020)... ... ... SEAL SHIELD, LLC - Almost a hundred thousand people are dying in ... Centers for Disease Control (CDC), 80% of infections are transmitted by hands. But what ... as an extension of people’s hands, but not getting cleaned nearly as often, if ...
(Date:2/16/2020)... ... February 16, 2020 , ... ... that it is partnering with AABB and The Joint Commission to provide a ... for PBM teams (directors, managers, coordinators and transfusion safety officers) within U.S. hospitals. ...
Breaking Medicine News(10 mins):
(Date:2/23/2020)... ... February 23, 2020 , ... ... an examination of the complex interplay between the brain, central nervous system and ... time at the International Association of Eating Disorders Professionals (iaedp™) 2020 Symposium in ...
(Date:2/20/2020)... PLAINS, N.J. (PRWEB) , ... February 20, 2020 , ... ... new location at 27 Mountain Blvd. in Warren, NJ on Thursday, January 16 at ... staff and local elected officials for the ribbon-cutting ceremony. Members of the public and ...
(Date:2/20/2020)... ... February 20, 2020 , ... ... has been selected to perform Independent Verification and Validation (IV&V) services for ... Exchange and Integrated Eligibility System (HIX/IES) project. , EOHHS, along with the ...
Breaking Medicine Technology: